Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.19 | -0.076 | -0.001 |
| % Growth | -57.9% | -149% | -6,258.3% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | – |
| Capital Expenditures | -$0 | $0 | $0 | – |
| Free Cash Flow | -$0 | -$0 | -$0 | – |